International Conference on Antiviral Research 2022
Attendees
- Kara Carter, Entrepreneur in Residence at Evotec
- Jon Gunther, Senior Director Business Development at Just – Evotec Biologics
- Antoine Alam, VP, Head of Virology at Evotec
- Cristina Loomis, Principal Scientist, Antibody Discovery at Just-Evotec Biologics
- Randal Ketchem, SVP Biotherapeutic Discovery and Molecular Design at Just – Evotec Biologics
- Claire White, Business Development at Evotec
Presentation | March 24th at 2:45 pm – 5:45 pm
AI-Derived Antibody Discovery – Humanoids for Global Good
- Randal Ketchem, SVP Biotherapeutic Discovery and Molecular Design at Just – Evotec Biologics
Presentation | March 23rd at 12:15 pm – 1:00 pm
A Bifunctional Immune Modulator Exhibits Potent Antiviral Activity in HBV Infection Models
- Antoine Alam, Head of Virology at Evotec
Poster
AI-Derived Antibodies Are Novel, Diverse and Pharmacologically Active Against Multiple Sars-Cov-2 Strains
- Cristina Loomis, Principle Scientist, Antibody Discovery at Just-Evotec Biologics
Kara Carter will be chairing four sessions:
- Monday, March 21 at 4:30 pm – 5:30 pm
Gertrude Elion Memorial Award Lecture - Tuesday, March 22 at 2:00 pm – 2:45 pm
William Prusoff Memorial Award Lecture - Wednesday, March 23 at 8:30 am – 9:15 am
Antonín Holý Memorial Award Lecture - Thursday, March 24 at 2:45 pm – 5:45 pm
Coronaviruses
We hope to see you there!
Speakers
-
Antoine AlamVP Head of Virology
With over 20 years of experience in the field, Antoine Alam bring extensive knowledge in virology and immunology to Just – Evotec Biologics. He has received a Ph.D. in Immunology from the Université Paul Sabatier Toulouse III.
-
Cristina LoomisPrincipal Scientist, Antibody Discovery
In her 10+ years of experience Cristina has accumulated extensive biopharmaceutical industry experience in discovery and preclinical development of therapeutic antibodies and biologics. She has contributed to preclinical work for the progression of numerous therapeutics that were brought forward to clinical development, including two immune-oncology and two migraine treatment drugs. Christina is specialized in preclinical development, in vitro and in vivo pharmacology, in vivo fluorescence microscopy, immune-oncology, immunological assays and neurobiology. She has received her PhD in Immunology from McGill University.
-
Randal KetchemSVP Discovery and Molecular Design
Randy received his PhD in Molecular Biophysics from Florida State University, focusing on experimental protein structure determination, resulting in the first membrane-bound protein structure solved by Solid State NMR. As part of this effort he developed computational methods for the structure calculation and refinement of membrane-bound proteins. Randy continued his training in structural biology in a postdoctoral fellowship at The Scripps Research Institute where he expanded his experimental and computational efforts into solution-based protein structure. Randy then joined Immunex in 1997 to apply his expertise in protein structure modelling and analysis to efforts in the development of biologic-based therapeutics. During his many years of experience at Immunex, Amgen, and Just Biotherapeutics he has led efforts to engineer protein therapeutics, invented novel therapeutic modalities and computational methods for therapeutic design, and developed computational and experimental approaches to understanding and controlling biophysical properties of biological macromolecules. Randy has made significant contributions in antibody design, epitope mapping, molecular assessment, stability engineering, construct design, protein structure analysis, and protein engineering. At Just – Evotec Biologics, Randy leads the Molecular Design team, integrating biologics discovery and molecular design strategies into the entire therapeutic pipeline.